MedPath
TGA Approval

ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial (203372)

203372

ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial

Takeda Pharmaceuticals Australia Pty Ltd

December 20, 2013

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-CMI-01559-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2014-PI-01042-1

Active Ingredients

Brentuximab vedotin

© Copyright 2025. All Rights Reserved by MedPath
ADCETRIS brentuximab vedotin (rch) 50 mg powder for injection vial (203372) - TGA 批准文号 | MedPath